Tactile Systems Technology Inc (TCMD)

NASD · Healthcare · Medical Devices · USA

Tactile Systems Technology Inc is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.

Tactile Systems Technology develops medical devices for treating chronic diseases at home, including compression therapy systems for lymphedema and chronic venous insufficiency, and airway clearance products for respiratory conditions. The company serves patients through direct-to-patient and durable medical equipment distribution models, partnering with clinicians and payers across the United States.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Tactile Systems Technology Inc stock.

Our verdict on TCMD

Fairly valued: intrinsic value $26.28 per share, market price $26.05, margin of safety 0.9% (as of 2026-11-17).

Discounting its cash flows at 9.5% (average of 3 methods) values the shares at $26.28; the price of $26.05 is 1% below that value, and 75% of that value comes from beyond year five.

ETFs with the most weight in TCMD

17 more funds hold it; the full list is part of the paid plan.

More on TCMD

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than TCMD in Medical Devices

14 more in this industry show a wider margin of safety.

Is TCMD undervalued or overvalued?

TCMD is fairly valued (as of the 2026-11-17 close). Discounting its cash flows at 9.5% (average of 3 methods) values the shares at $26.28; the price of $26.05 is 1% below that value, and 75% of that value comes from beyond year five.

What is the intrinsic value of TCMD?

$26.28 per share (as of the 2026-11-17 close), against a market price of $26.05. That is a margin of safety of 0.9%. The value is the average of the 3 valuation methods that apply to this company, recomputed every night after the US close.